Scarica l'app Stockscreener
126.74
5.29%
6.37
Dopo l'orario di chiusura:
126.63
-0.11
-0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$120.37
Aprire:
$121.72
Volume 24 ore:
2.40M
Relative Volume:
1.31
Capitalizzazione di mercato:
$19.25B
Reddito:
$4.34B
Utile/perdita netta:
$850.00M
Rapporto P/E:
23.20
EPS:
5.4635
Flusso di cassa netto:
$921.00M
1 W Prestazione:
+1.04%
1M Prestazione:
+2.82%
6M Prestazione:
+2.59%
1 anno Prestazione:
+63.32%
Intervallo 1D:
$121.43
$128.12
Intervallo di 1 settimana:
$119.14
$129.28
Portata 52W:
$73.86
$155.53
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
126.74 | 19.28B | 4.34B | 850.00M | 921.00M | 5.4635 |
TMO
Thermo Fisher Scientific Inc
|
478.96 | 174.74B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
178.95 | 126.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.80 | 45.14B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.55 | 32.46B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
309.23 | 29.52B | 3.17B | 642.63M | 516.49M | 10.77 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo News Malaysia
Illumina Q1 Earnings Call Highlights - Yahoo Finance
Illumina Q1 2026 slides: earnings beat on clinical strength, margins expand - Investing.com India
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Earnings call transcript: Illumina beats Q1 2026 estimates, stock rises - Investing.com
Illumina (ILMN) Q1 2026 Earnings Transcript - The Motley Fool
Earnings call transcript: Illumina beats Q1 2026 estimates, stock rises By Investing.com - Investing.com Canada
Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026 - TradingView
Illumina lifts 2026 outlook and expands share buybacks - TipRanks
(ILMN) Illumina Expects Fiscal 2026 Adjusted EPS Range $5.15-$5.30, vs. FactSet Est of $5.12 - marketscreener.com
Illumina: Q1 Earnings Snapshot - 10TV
Earnings Flash (ILMN) Illumina, Inc. Reports Q1 Revenue $1.09B, vs. FactSet Est of $1.07B - marketscreener.com
[8-K] ILLUMINA, INC. Reports Material Event - Stock Titan
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 - PR Newswire
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now? - TradingView
Illumina set to report earnings amid rising Roche competition By Investing.com - Investing.com Australia
Vanguard reports 7.94M shares in Illumina (ILMN) Schedule 13G - Stock Titan
Illumina Inc. Stock (US4523271090): Q1 2026 Earnings Release Expected Today - AD HOC NEWS
Discipline and Rules-Based Execution in ILMN Response - Stock Traders Daily
Illumina (ILMN) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Will DRAGEN v4.5’s ML-Powered Genomics Upgrade Reshape Illumina’s (ILMN) Precision Medicine Narrative? - Yahoo Finance
Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Illumina (ILMN) Q1 earnings report preview: What to look for - MSN
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Illumina, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics - Markets Mojo
Prenatal Testing Services Market key players 2025-2031 : Illumina Inc, Centogene NV., Revvity, Inc. etc - openPR.com
Illumina, Inc. (ILMN) Stock Analysis: Unveiling Growth Potential With A Promising Upside - DirectorsTalk Interviews
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
Illumina, Inc. $ILMN Shares Sold by KLP Kapitalforvaltning AS - MarketBeat
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - Illumina
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
ILMN CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. (ILMN) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Universal Beteiligungs und Servicegesellschaft mbH Sells 15,739 Shares of Illumina, Inc. $ILMN - MarketBeat
Human Microbiome Sequencing Technology Market Competitive - openPR.com
Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
AML Complexity Uncovered: - Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DNA Extraction, Isolation and Purification Market: Key Players - openPR.com
OVERSEA CHINESE BANKING Corp Ltd Decreases Stock Position in Illumina, Inc. $ILMN - MarketBeat
Gene Expression Analysis Market Set for Robust Growth to USD - openPR.com
Illumina Inc. (ILMN) – Pediatric Genomics Collaboration Bolsters Long-Term Growth Narrative Amid Mixed Historical ReturnsFast Rising Picks - Cổng thông tin điện tử tỉnh Tây Ninh
Belpointe Asset Management LLC Purchases Shares of 9,592 Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. (ILMN) Launches DRAGEN v4.5 Bioinformatics Suite, Expanding Addressable Market in Genomic Research and Clinical OncologyPost Announcement - Xã Thanh Hà
ILMN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
South America Next Generation Sequencing eDNA Biomonitoring - openPR.com
Metagenomics Market Key Companies AnalysisMerck KGaA, Thermo - openPR.com
Pharmacogenomics Market Leading Companies | F. Hoffmann-la - openPR.com
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.13%
2.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):